Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Sale of Stock [Axis]
At-The-Market Offering Program [Member]
Private Placement [Member]
Asset Class [Axis]
Money Market Funds [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Award Date [Axis]
2013 Through March 31, 2026 [Member]
Legal Entity [Axis]
Israeli Innovation Authority [Member]
Business Combination [Axis]
CardioSert Ltd [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Ministry of Economy [Member]
Technion Research and Development Foundation Limited [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
At-the-Market Offering Agreement [Member]
H.C. Wainwright & Co. LLC [Member]
Product and Service [Axis]
Device [Member]
Integrated Product [Member]
Title and Position [Axis]
Chief Executive Officer and Executives and Certain Employees [Member]
Securities Purchase Agreement [Member]
Series F Preferred Investment Options [Member]
Series G Preferred Investment Options [Member]
Series H Preferred Investment Options [Member]
Series I Preferred Investment Options [Member]
Placement Agent Preferred Investment Options [Member]
Class of Stock [Axis]
Series E, G, H, I and Series F Preferred Investment Options [Member]
The Letter Agreement [Member]
Series J Preferred Investment Options [Member]
Award Type [Axis]
Preferred Investment Options [Member]
Derivative Instrument [Axis]
Second Closing [Member]
Third Closing [Member]
Wainwright [Member]
Performance Shares [Member]
Plan Name [Axis]
2020 Omnibus Performance Award Plan [Member]
Chief Executive Officer [Member]
Other Executives andCertain Employees [Member]
Certain Board Members [Member]
Former Advisor [Member]
Executives [Member]
Warrant To Underwriters October 2022 [Member]
Warrant To Underwriters May 2023 [Member]
Warrant To Underwriters May 2023 One [Member]
Warrant to Underwriters June 2023 [Member]
Warrant to Underwriters June 2023 One [Member]
Warrant to Underwriters January 2024 [Member]
Warrant to Underwriters June 2024 [Member]
Warrant To Underwriters January 2025 [Member]
Warrant To Underwriters January 2025 One [Member]
Warrant To Underwriters January 2025 Two [Member]
Warrant to Underwriters February 2025 [Member]
Warrant To Underwriters September 2025 [Member]
Warrant To Underwriters September 2025 One [Member]
Warrant To Underwriters September 2025 Two [Member]
Warrant To Underwriters September 2025 Three [Member]
Warrant To Underwriters September 2025 Four [Member]
Warrant To Underwriters September 2025 Five [Member]
Warrant To Underwriters September 2025 Six [Member]
Warrant To Underwriters September 2025 Seven [Member]
Warrant To Underwriters September 2025 Eight [Member]
Warrant to Underwriters September 2025 Nine [Member]
Warrant Series J September 2025 [Member]
Warrant Series J September 2025 One [Member]
Warrant Series J October 2025 One [Member]
Warrant To Underwriters October Two Thousand Twenty Five [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Statement of Financial Position [Abstract]
ASSETS
Current assets:
Cash and cash equivalents
Marketable securities
Restricted cash
Restricted deposit
Accounts receivable
Inventory
Prepaid expenses and other current assets
Total current assets
Long-term assets:
Restricted cash
Long-term deposit
Property and equipment, net
Operating right-of-use assets
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Lease liabilities
Accrued liabilities
Total current liabilities
Non-current liabilities:
Long-term lease liabilities, net of current portion
Total liabilities
Shareholders’ equity:
Common stock; $0.01 par value; 120,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 67,158,044 shares issued and outstanding as of March 31, 2026 and December 31, 2025
Additional paid-in capital
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Revenues
Cost of revenues
Gross profit
Research and development, net
Sales, general and administrative
Operating loss
Other income (see Note 3F)
Financing income, net
Net loss
Basic net loss per share
Diluted net loss per share
Basic weighted average common shares outstanding
Diluted weighted average common shares outstanding
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Issuance of common stock and warrants, net
Issuance of common stock and warrants, net, shares
Issuance of common stock under the at-the-market offering program, net
Issuance of common stock under the at-the-market offering program, net, shares
Issuance of common stock upon exercise of warrants, net
Issuance of common stock upon exercise of warrants, net, shares
Share-based compensation
Net loss
Balance
Balance, shares
Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]
Subsidiary, Sale of Stock [Line Items]
Common stock and warrants issuance costs
Stock issuance cost not paid
Statement of Cash Flows [Abstract]
Operating activities:
Adjustments to reconcile net loss to net cash flows used in operating activities:
Depreciation of property and equipment
Interest income and unrealized gains from marketable securities
Share-based compensation
Changes in assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other assets
Other payables and accrued liabilities
Net cash flows used in operating activities
Investing activities:
Purchases of property and equipment
Purchases of marketable securities
Proceeds from sales of a marketable securities
Increase in long-term deposit
Increase in restricted deposit
Net cash flows provided by (used in) investing activities
Financing activities:
Issuance of common stock and warrants, net of issuance costs
Net cash flows provided by financing activities
(Decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosure of non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease liabilities
Deferred issuance costs
Issuance costs not paid
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Equity [Abstract]
SHARE CAPITAL
Segment Reporting [Abstract]
SEGMENT REPORTING
Leases
LEASES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of presentation
Use of estimates
Revenues
Cost of revenues
Fair value of financial instruments
Allowance for credit losses
Share-based compensation
Recent Accounting Pronouncements:
SCHEDULE OF FINANCIAL ASSETS SUBJECT TO FAIR VALUE MEASUREMENT
SCHEDULE OF WARRANTS OUTSTANDING
SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES BY SEGMENT
SCHEDULE OF FUTURE MINIMUM LEASE OBLIGATIONS
SCHEDULE OF WEIGHTED-AVERAGE LEASE TERMS AND DISCOUNT RATES
Cash equivalents and marketable securities
Impairment Effects on Earnings Per Share [Table]
Impairment Effects on Earnings Per Share [Line Items]
Marketable securities
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Revenue from Contract with Customer, Including Assessed Tax
Grants Receivable
[custom:AdditionalGrantReceivable-0]
Repayment of government grants
Net sales royalty percenatge
Offering costs
Aggregate offering
Percentage of placement fee
Gross proceeds from cash fee percentage
Gross proceeds from management fee percentage
Warrants description
Assets consideration
Royalties percentage
Proceeds from legal settlements
Accrued bonuses
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants outstanding and exercisable
Exercise price
Exercisable Through
Issued shares
Share price
Gross proceeds from offering
Offering expense
Common stock, issuance and sale value
Total gross proceeds
Other offering expenses
Options exercised, consideration
Options outstanding
Placement agent cash fees
Options granted
Proceeds from options
Options exercised
Total authorized shares
Preferred stock, shares authorized
Options to purchase common stock
Share price per share
Proceeds from exercise of existing preferred investment options
Inducement transaction cost
Unpaid amount
Options vested
Options forfeited
Common stock capital shares reserved for future issuance
Options, exercise price
Payroll and payroll related
Materials and subcontractors
Share-based compensation
Other segment items
Number of operating segments
Number of reportable segments
Schedule Of Future Minimum Lease Obligations
2026
2027
2028
2029
Total future lease payments
Less imputed interest
Total lease liabilities
Schedule Of Weighted-average Lease Terms And Discount Rates
Operating leases weighted average remaining lease term (in years)
Operating leases weighted average discount rate
Finance lease principal payments
Bank guarantee issued amount
lease cost
Cash paid under operating lease agreements
Right-of-use assets
Subsequent Event [Table]
Subsequent Event [Line Items]
Numbe rof shares issued
Numbe rof shares issued
Offering expenses
Share based compensation granted
Share based compensation employees
Stock issued during period value warrants exercised.
Stock issued during period shares warrants exercised.
At-The-Market Offering Program [Member]
Stock issuance costs payable.
Payments to increase long-term deposit.
Deferred issuance costs.
Issuance costs not paid.
Accounting Pronouncements Not Yet Effective [Policy Text Block]
Israeli Innovation Authority [Member]
Additional grant receivable.
Repayment of government grants.
CardioSert Ltd [Member]
Net sales royalty percentage.
Ministry of Economy [Member]
Technion Research And Development Foundation Limited [Member]
Offering costs.
At-the-Market Offering Agreement [Member]
H.C. Wainwright & Co. LLC [Member]
Placement fee percent.
Gross proceeds from cash fee percentage.
Gross proceeds from management fee percentage.
Royalties percent.
Device [Member]
Integrated Product [Member]
Securities Purchase Agreement [Member]
Litigation Settlement [Member]
Insurance recovery amount.
2013 Through March 31, 2026 [Member]
Chief Executive Officer and Executives and Certain Employees [Member]
Series A Preferred Investment Options [Member]
Series C Preferred Investment Options [Member]
Series D Preferred Investment Options [Member]
Existing Preferred Investment Options [Member]
Inducement Investment Options [Member]
Agent fees and other offering expenses.
Preferred Investment Option Exercise Inducement Offers Letter [Member]
Series F Preferred Investment Options [Member]
Series G Preferred Investment Options [Member]
Series H Preferred Investment Options [Member]
Series I Preferred Investment Options [Member]
Placement Agent Preferred Investment Options [Member]
Series E, G, H, I and Series F Preferred Investment Options [Member]
The Letter Agreement [Member]
Series J Preferred Investment Options [Member]
Preferred Investment Options [Member]
Second Closing [Member]
Third Closing [Member]
Inducement transaction cost.
Unpaid amount.
Wainwright [Member]
2020 Omnibus Performance Award Plan [Member]
Executives [Member]
Other Executives andCertain Employees [Member]
Certain Board Members [Member]
Former Advisor [Member]
Warrant To Underwriters October 2022 [Member]
Warrant To Underwriters May 2023 [Member]
Warrant To Underwriters May 2023 One [Member]
Warrant to Underwriters June 2023 [Member]
Warrant to Underwriters June 2023 One [Member]
Warrant Series E January 2024 [Member]
Warrant to Underwriters January 2024 [Member]
Warrant Series F June 2024 [Member]
Warrant to Underwriters June 2024 [Member]
Warrant To Underwriters January 2025 [Member]
Warrant To Underwriters January 2025 One [Member]
Warrant To Underwriters January 2025 Two [Member]
Warrant to Underwriters February 2025 [Member]
Warrant To Underwriters September 2025 [Member]
Warrant To Underwriters September 2025 One [Member]
Warrant To Underwriters September 2025 Two [Member]
Warrant To Underwriters September 2025 Three [Member]
Warrant To Underwriters September 2025 Four [Member]
Warrant To Underwriters September 2025 Five [Member]
Warrant To Underwriters September 2025 Six [Member]
Warrant To Underwriters September 2025 Seven [Member]
Warrant To Underwriters September 2025 Eight [Member]
Warrant to Underwriters September 2025 Nine [Member]
Warrant Series J September 2025 [Member]
Warrant Series J September 2025 One [Member]
Warrant Series J October 2025 One [Member]
Warrant Series J October 2025 Two [Member]
Bank guarantee issued.
Schedule of Weighted-average Lease Terms and Discount Rates [Table Text Block]
Payroll and payroll related expenses.
Materials and subcontractors expenses.
Cost of Revenues [Policy Text Block]
Assets, Current
Restricted Cash and Cash Equivalent, Noncurrent
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Cost of Revenue
Gross Profit
Research and Development Expense
Selling, General and Administrative Expense
Operating Income (Loss)
Shares, Outstanding
Marketable Security, Unrealized Gain (Loss)
Share-Based Payment Arrangement, Noncash Expense
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Marketable Securities
PaymentsToIncreaseLongtermDeposit
Payments to Acquire Restricted Investments
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Revenue [Policy Text Block]
Share-Based Payment Arrangement [Policy Text Block]
Assets, Fair Value Disclosure
PayrollAndPayrollRelatedExpenses
MaterialsAndSubcontractorsExpenses
Segment Reporting, Other Segment Item, Amount
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Operating Lease, Liability